Z. Yang, B. Yu / Carbohydrate Research 333 (2001) 105–114
113
Anal. Calcd for C44H64O6S: C, 73.29; H, 8.95.
Found: C, 73.11; H, 9.24.
H-1%), 5.33 (dd, 1 H, J 11.3, 9.3 Hz), 5.09 (t, 1
H, J 9.3 Hz), 4.70 (d, 1 H, J 9.0 Hz, H-1),
4.19–4.13 (m, 2 H, H-2%, H-3%), 4.00–3.92 (dd,
1 H, J 10.2, 6.3 Hz, H-4%), 3.68–3.54 (m, 2 H,
H-5%, H-5), 3.38 (dd, 1 H, J 11.3, 8.8 Hz, H-2),
2.66–2.44 (m, 2 H, SCH2), 1.83 (s, 3 H, Ac),
1.53, (s, 6 H, (CH3)2C), 1.36–1.25 (m, 9 H).
EIMS (m/z, %): 571 ([M+−SEt], 1.1), 385
([M+−Rhamno], 5.7), 203 (95.2), 105 (Bz,
100). Anal. Calcd for C32H40O9S2: C, 60.74; H,
6.37. Found: C, 61.01; H, 6.57.
Ethyl 3-O-acetyl-4,6-O-benzylidene-2-S-
ethyl-2-thio-i-
D
-glucopyranoside
(35).—1H
NMR (CDCl3): l 7.44–7.32 (m, 5 H), 5.49 (s,
1 H, CHPh), 5.08 (dd, 1 H, J 11.0, 9.5 Hz,
H-3), 4.52 (d, 1 H, J 8.8 Hz, H-1), 4.32 (dd, 1
H, J 10.3, 5.1 Hz, H-4), 3.97 (m, 1 H), 3.78 (t,
1 H, J 10.3 Hz, H-6), 3.66 (m, 1 H), 3.62 (t, 1
H, J 9.5 Hz, H-6%), 3.46 (dt, 1 H, J 9.5, 5.1 Hz,
H-5), 2.79–2.60 (m, 3 H, H-2, SCH2), 2.11 (s,
3 H, Ac), 1.25–1.20 (m, 6 H).
Ethyl 3-O-acetyl-4-O-benzoyl-6-deoxy-2-S-
Cyclohexanyl 3-O-acetyl-4,6-O-benzylidene-
phenyl-2-thio-i- -glucopyranoside (32).—[h]D
L
1
2-S-ethyl-2-thio-h/i- -glucopyranoside (36).
D
+61.2° (c 1.0, CHCl3); H NMR (CDCl3): l
7.99–7.27 (m, 10 H), 5.28 (dd, 1 H, J 11.3, 9.3
Hz, H-3), 5.02 (t, 1 H, J 9.5 Hz, H-4), 4.34 (d,
1 H, J 8.8 Hz, H-1), 3.99–3.88 (m, 1 H, H-5),
3.64–3.52 (m, 2 H, OCH2), 3.17 (dd, 1 H, J
11.3, 8.8 Hz, H-2), 1.89 (s, 3 H, Ac), 1.23 (m,
6 H). EIMS (m/z, %): 430 ([M+], 0.6), 105
(Bz, 100). Anal. Calcd for C28H26O6S: C,
64.17; H, 6.09. Found: C, 64.47; H, 6.32.
3-O-Acetyl-4-O-benzoyl-6-deoxy-2-S-phenyl-
1
—(a:b=2:3). H NMR (CDCl3): l 7.44–7.32
(m, 5 H), 5.52–5.50 (m, 1.4 H, PhCH, H-1a),
5.12–5.05 (m, 1 H, H-3), 4.63 (d, 0.6 H, J 8.8
Hz, H-1b), 4.62 (dd, 0.6 H, J 10.6, 4.9 Hz,
H-4b), 4.50 (dd, 0.4 H, J 10.2, 4.9 Hz, H-4a),
4.15–4.02 (m, 0.4 H, H-5a), 3.83–3.55 (2×m,
3 H, H-6, OCH(CH2)5), 3.50–3.42 (m, 3 H,
SCH2CH3).
Cholesteryl 3,4,6-tri-O-acetyl-2-S-ethyl-2-
thio-i- -glucopyranoside (37).—[h]D −4.8°
D
2-thio-i-
L
-glucopyranosyl-(16)-1,2;3,4-di-
-galactopyranoside (33).
1
(c 0.4, CHCl3); H NMR (CDCl3): l 5.39 (m,
1 H, H-6), 5.01 (t, 1 H, J 9.3 Hz), 4.93 (t, 1 H,
J 9.9 Hz), 4.54 (d, 1 H, J 8.8 Hz, H-1%), 4.30
(dd, 1 H, J 11.9, 4.8 Hz, H-6%), 4.08 (dd, 1 H,
J 12.1, 2.2 Hz, H-6%), 3.66–3.54 (m, 2 H, H-5%,
H-3), 2.80–2.60 (m, 3 H, H-2%, SCH2), 2.44–
2.22 (m, 2 H), 2.12, (s, 6 H, 2×Ac), 2.02 (s, 3
H, Ac). EIMS (m/z, %): 703 ([M+−Me], 0.2),
659 ([M+−SEt], 0.3), 369 ([M+−Man], 100).
Anal. Calcd for C41H66O8S: C, 68.48; H, 9.25.
Found: C, 68.28; H, 9.27.
O-isopropylidene-h-
D
—[h]D −10.0° (c 0.9, CHCl3); 1H NMR
(CDCl3): l 7.98–7.22 (m, 10 H), 5.54 (d, 1 H,
J 4.9 Hz, H-1), 5.27 (dd, 1 H, J 11.2, 9.3 Hz,
H-3%), 5.02 (t, 1 H, J 9.5 Hz, H-4%), 4.58 (dd, 1
H, J 8.0, 2.2 Hz, H-3), 4.42 (d, 1 H, J 8.8 Hz,
H-1%), 4.34–4.29 (m, 2 H, H-2, H-4), 4.01–
3.97 (m, 2 H, H-6), 3.81–3.74 (m, 1 H, H-5),
3.61–3.56 (m, 1 H, H-5%), 3.18 (dd, 1 H, J
11.3, 8.8 Hz, H-2%), 1.92 (s, 3 H, Ac), 1.49 (s,
6 H), 1.36, 1.34 (2×s, 2×3 H), 1.24 (d, 3 H,
J 6.2 Hz). EIMS (m/z, %): 644 ([M+], 0.2),
203 (23.8), 152 (43.6), 105 (Bz, 100). Anal.
Calcd for C33H40O11S: C, 61.48; H, 6.25.
Found: C, 61.41; H, 6.40.
Ethyl 3,4,6-tri-O-acetyl-2-S-ethyl-2-thio-i-
D
-glucopyranoside (38).—[h]D +22.2° (c 1.1,
1
CHCl3); H NMR (CDCl3): l 5.03 (t, 1 H, J
9.1 Hz), 4.94 (dd, 1 H, J 11.0, 9.1 Hz), 4.42 (d,
1 H, J 8.8 Hz, H-1), 4.30 (dd, 1 H, J 12.4, 4.9
Hz, H-6), 4.12 (dd, 1 H, J 12.1, 2.2 Hz, H-6),
4.04–3.94 (m, 1 H, H-5), 3.71–3.59 (m, 2 H,
OCH2), 2.82–2.60 (m, 3 H, H-2, SCH2), 2.09,
2.08, 2.02 (3×s, 9 H, 3×Ac), 1.28–1.23 (m,
6 H, SCH2CH3, OCH2CH3). EIMS (m/z, %):
377 ([M++1], 0.8), 333 ([M+ −OEt], 2.4).
Anal. Calcd for C16H26O8S: C, 50.78; H, 6.82.
Found: C, 50.63; H, 6.83.
Cholesteryl 3-O-acetyl-4,6-O-benzylidene-2-
S-ethyl-2-thio-h/i- -glucopyranoside (34).—
D
1
(a:b=1:4). H NMR (CDCl3): l 7.44–7.32
(m, 5 H), 5.51–5.49 (m, 1.2 H, PhCH, 0.2
H-1a), 5.40 (m, 0.8 H, H-6%), 5.34 (m, 0.2 H,
b
H-6%), 5.12–5.05 (m, 1 H, H-3), 4,63 (d, 0.8 H,
a
J 8.7 Hz, H-1b), 4.32–4.23 (m, 1 H, H-4),
4.14–4.04 (m, 0.2 H, H-5a), 3.82–3.56 (2×m,
3 H, H-6, H-3%), 3.50–3.45 (m, 0.8 H, H-5b),
2.82–2.61 (m, 3 H, H-2, SCH2), 2.48–2.22
(2×m, 2 H), 2.10 (s, 3 H, Ac). EIMS (m/z,
%): 721 ([M+], 4.1), 369 ([M+−Gluco], 100).
3,4,6-Tri-O-acetyl-2-S-ethyl-2-thio-i-
glucopyranosyl-(16)-1,2;3,4-di-O-isoprop-
ylidene-h- -galactopyranoside (39).—[h]D
33.4° (c 1.0, CHCl3); H NMR (CDCl3): l
D
-
D
−
1